Adults with obesity or overweight and prediabetes had a 94 per cent lower risk of progressing to type 2 diabetes after taking tirzepatide, drugmaker Eli Lilly and Co. reported.

A significant increase in children walking and cycling to school has been credited for a notable reduction in childhood obesity rates in Guernsey.

A recent trial, published in The New England Journal of Medicine and presented at the European Association for the Study of Diabetes Obesity (EASD), demonstrated that liraglutide effectively lowered body mass index (BMI) in children, but the occurrence of side effects indicates a need for further research.

On October 16, 2024, the Obesity Health Alliance (OHA) will launch a new position statement calling for significant policy changes to improve obesity management services across England.

Following the incredible success of the inaugural event held earlier this year in Birmingham, the 2025 conference will take place in London, offering excellent transport links and accessibility for UK registered healthcare professionals.

Liverpool City Council is exploring a proposal to ban junk food advertisements on its billboards and properties in an effort to address the city's growing obesity problem.

Researchers found that higher levels of interleukin-6 were associated with increased risk of obesity-related cancers in people who have recently been diagnosed with type 2 diabetes.

Individuals who received a once-a-day oral weight loss drug lost up to 13 per cent of their body weight over three months, according to research presented at EASD 2024.

Semaglutide, a drug commonly prescribed under the brand names Ozempic and Wegovy for treating Type 2 diabetes and obesity, may also have the potential to slow down the ageing process, according to new research.

Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, new research presented at the European Association for the Study of Diabetes (EASD) has suggested.

A recent study from Oregon Health & Science University (OHSU) has highlighted the connection between misaligned circadian rhythms and increased metabolic risk factors in individuals living with overweight or obesity.

Intermittent fasting is just as effective as traditional calorie restriction for weight loss in teenagers with obesity, according to a new Australian study.

The growing child obesity crisis in England has been highlighted by an interactive map showing areas where nearly half of children are living with overweight or obesity by the time they enter secondary school.

A recent study sheds light on the possible connection between obesity and a higher risk of multiple sclerosis (MS) in women, suggesting that inflammation specific to females may play a crucial role in this increased susceptibility.

Gaining even a small amount of weight could significantly impact the metabolic health of young South Asian men, according to a recent study led by the University of Glasgow and published in Nature Metabolism.

Academics at the University of Liverpool have found that the weight loss drug, Tirzepatide is associated with a significantly reduced risk of developing type 2 diabetes.

A recent study at ETH Zurich sheds light on why the choice between exercise and indulging in a treat isn't just a matter of willpower. The study reveals that a brain chemical called orexin plays a crucial role in tipping the balance between physical activity and indulgence.

A recent clinical trial has shown that an older obesity drug from Novo Nordisk, known for its weight loss benefits, may have a positive effect on brain health in patients with mild Alzheimer's disease. The trial, which involved just 204 patients in Britain, provides an early indication of how GLP-1 receptor agonist drugs might work on challenging brain disorders.

A recent study published in The Lancet Public Health has revealed a significant link between higher BMI in early adulthood and an increased risk of cardiovascular diseases in a Chinese population.